OTCMKTS:MDCL

Medicine Man Technologies Competitors

$2.39
+0.31 (+14.90 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.02
Now: $2.39
$2.54
50-Day Range
$1.90
MA: $2.26
$2.80
52-Week Range
$1.05
Now: $2.39
$4.05
Volume211,494 shs
Average Volume84,948 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Medicine Man Technologies (OTCMKTS:MDCL) Vs. IIPR, GRWG, XXII, KSHB, NSAV, and TRTC

Should you be buying MDCL stock or one of its competitors? Companies in the sub-industry of "cannabis" are considered alternatives and competitors to Medicine Man Technologies, including Innovative Industrial Properties (IIPR), GrowGeneration (GRWG), 22nd Century Group (XXII), KushCo (KSHB), NSAV (NSAV), and Terra Tech (TRTC).

Medicine Man Technologies (OTCMKTS:MDCL) and Innovative Industrial Properties (NYSE:IIPR) are both industrials companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership.

Valuation and Earnings

This table compares Medicine Man Technologies and Innovative Industrial Properties' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medicine Man TechnologiesN/AN/AN/AN/AN/A
Innovative Industrial Properties$44.67 million96.87$23.48 million$3.2755.31

Innovative Industrial Properties has higher revenue and earnings than Medicine Man Technologies.

Analyst Ratings

This is a summary of current ratings for Medicine Man Technologies and Innovative Industrial Properties, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medicine Man Technologies0000N/A
Innovative Industrial Properties02502.71

Innovative Industrial Properties has a consensus price target of $192.4286, suggesting a potential upside of 6.57%. Given Innovative Industrial Properties' higher possible upside, analysts clearly believe Innovative Industrial Properties is more favorable than Medicine Man Technologies.

Institutional & Insider Ownership

74.9% of Innovative Industrial Properties shares are owned by institutional investors. 2.9% of Innovative Industrial Properties shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Medicine Man Technologies and Innovative Industrial Properties' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medicine Man TechnologiesN/AN/AN/A
Innovative Industrial Properties55.71%6.05%4.82%

Summary

Innovative Industrial Properties beats Medicine Man Technologies on 8 of the 8 factors compared between the two stocks.

Medicine Man Technologies (OTCMKTS:MDCL) and GrowGeneration (NASDAQ:GRWG) are both industrials companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership.

Valuation and Earnings

This table compares Medicine Man Technologies and GrowGeneration's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medicine Man TechnologiesN/AN/AN/AN/AN/A
GrowGeneration$79 million33.68$1.88 million$0.10455.10

GrowGeneration has higher revenue and earnings than Medicine Man Technologies.

Analyst Ratings

This is a summary of current ratings for Medicine Man Technologies and GrowGeneration, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medicine Man Technologies0000N/A
GrowGeneration03502.63

GrowGeneration has a consensus price target of $49.5714, suggesting a potential upside of 8.78%. Given GrowGeneration's higher possible upside, analysts clearly believe GrowGeneration is more favorable than Medicine Man Technologies.

Institutional & Insider Ownership

51.3% of GrowGeneration shares are owned by institutional investors. 13.6% of GrowGeneration shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Medicine Man Technologies and GrowGeneration's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medicine Man TechnologiesN/AN/AN/A
GrowGeneration2.14%4.68%3.53%

Summary

GrowGeneration beats Medicine Man Technologies on 8 of the 8 factors compared between the two stocks.

Medicine Man Technologies (OTCMKTS:MDCL) and 22nd Century Group (NYSEAMERICAN:XXII) are both industrials companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership.

Valuation and Earnings

This table compares Medicine Man Technologies and 22nd Century Group's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medicine Man TechnologiesN/AN/AN/AN/AN/A
22nd Century GroupN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current ratings for Medicine Man Technologies and 22nd Century Group, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medicine Man Technologies0000N/A
22nd Century Group00103.00

Profitability

This table compares Medicine Man Technologies and 22nd Century Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medicine Man TechnologiesN/AN/AN/A
22nd Century GroupN/AN/AN/A

Summary

22nd Century Group beats Medicine Man Technologies on 1 of the 1 factors compared between the two stocks.

Medicine Man Technologies (OTCMKTS:MDCL) and KushCo (OTCMKTS:KSHB) are both industrials companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership.

Valuation and Earnings

This table compares Medicine Man Technologies and KushCo's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medicine Man TechnologiesN/AN/AN/AN/AN/A
KushCo$113.84 million1.65$-77,660,000.00($0.68)-1.74

Medicine Man Technologies has higher earnings, but lower revenue than KushCo.

Analyst Ratings

This is a summary of current ratings for Medicine Man Technologies and KushCo, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medicine Man Technologies0000N/A
KushCo01302.75

KushCo has a consensus price target of $1.8750, suggesting a potential upside of 58.90%. Given KushCo's higher possible upside, analysts clearly believe KushCo is more favorable than Medicine Man Technologies.

Profitability

This table compares Medicine Man Technologies and KushCo's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medicine Man TechnologiesN/AN/AN/A
KushCo-65.89%-47.95%-31.39%

Institutional & Insider Ownership

0.0% of KushCo shares are owned by institutional investors. 17.3% of KushCo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

KushCo beats Medicine Man Technologies on 5 of the 8 factors compared between the two stocks.

Medicine Man Technologies (OTCMKTS:MDCL) and NSAV (OTCMKTS:NSAV) are both industrials companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk.

Valuation & Earnings

This table compares Medicine Man Technologies and NSAV's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medicine Man TechnologiesN/AN/AN/AN/AN/A
NSAVN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Medicine Man Technologies and NSAV, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medicine Man Technologies0000N/A
NSAV0000N/A

Profitability

This table compares Medicine Man Technologies and NSAV's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medicine Man TechnologiesN/AN/AN/A
NSAVN/AN/AN/A

Medicine Man Technologies (OTCMKTS:MDCL) and Terra Tech (OTCMKTS:TRTC) are both industrials companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk.

Valuation & Earnings

This table compares Medicine Man Technologies and Terra Tech's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medicine Man TechnologiesN/AN/AN/AN/AN/A
Terra Tech$28.05 million2.15$-46,930,000.00N/AN/A

Medicine Man Technologies has higher earnings, but lower revenue than Terra Tech.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Medicine Man Technologies and Terra Tech, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medicine Man Technologies0000N/A
Terra Tech0000N/A

Profitability

This table compares Medicine Man Technologies and Terra Tech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medicine Man TechnologiesN/AN/AN/A
Terra Tech-261.88%-110.38%-62.41%

Institutional and Insider Ownership

0.1% of Terra Tech shares are held by institutional investors. 6.7% of Terra Tech shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.


Medicine Man Technologies Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Innovative Industrial Properties logo
IIPR
Innovative Industrial Properties
1.8$180.85+2.3%$4.42 billion$44.67 million58.53Analyst Revision
GrowGeneration logo
GRWG
GrowGeneration
1.7$45.51+3.5%$2.75 billion$79 million910.38Insider Selling
22nd Century Group logo
XXII
22nd Century Group
0.9$3.85+16.6%$489.20 millionN/A0.00Analyst Downgrade
Gap Down
KushCo logo
KSHB
KushCo
1.3$1.18+0.0%$187.47 million$113.84 million-1.97Gap Up
NSAV logo
NSAV
NSAV
0.3$0.02+1.1%$104.60 millionN/A0.00Gap Up
Terra Tech logo
TRTC
Terra Tech
0.7$0.26+3.7%$60.19 million$28.05 million0.00Decrease in Short Interest
Gap Up
General Cannabis logo
CANN
General Cannabis
0.6$0.68+4.4%$42.26 million$3.67 million0.00Gap Up
PVSP
Pervasip
0.4$0.01+0.0%$39.26 millionN/A0.00Increase in Short Interest
News Coverage
Gap Down
Grow Capital logo
GRWC
Grow Capital
0.6$1.09+8.3%$27.07 million$2.37 million0.00Gap Up
NMUS
Nemus Bioscience
0.6$0.12+0.0%$16.07 millionN/A0.00High Trading Volume
Leafbuyer Technologies logo
LBUY
Leafbuyer Technologies
0.5$0.16+6.5%$14.08 million$2.53 million0.00Gap Up
MassRoots logo
MSRT
MassRoots
0.6$0.02+1.8%$10.91 million$20,000.000.00
Peak Pharmaceuticals logo
PKPH
Peak Pharmaceuticals
0.7$0.13+1.5%$10.19 millionN/A0.00
FutureWorld logo
FWDG
FutureWorld
0.5$0.00+0.0%$4.56 millionN/A0.00Gap Up
Mentor Capital logo
MNTR
Mentor Capital
0.5$0.17+5.9%$3.86 million$4.33 million-4.23Gap Down
NGBL
Notis Global
0.5$0.00+0.0%$3.00 millionN/A0.00
DigiPath logo
DIGP
DigiPath
0.5$0.04+6.1%$2.89 million$2.55 million-1.41Gap Down
CrowdGather logo
CRWG
CrowdGather
0.7$0.01+23.0%$1.60 million$160,000.000.00Increase in Short Interest
Gap Down
United Cannabis logo
CNAB
United Cannabis
0.4$0.01+0.0%$1.23 millionN/A0.00High Trading Volume
OPMZ
1PM Industries
0.4$0.00+0.0%$0.00N/A0.00Gap Down
AQSP
Acquired Sales
0.4$7.90+1.3%$0.00N/A0.00
AMMJ
American Cannabis
0.5$0.19+0.1%$0.00N/A0.00Gap Down
AmeriCann logo
ACAN
AmeriCann
0.4$1.30+0.8%$0.00N/A0.00Gap Up
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.18+6.8%$0.00N/A0.00Gap Down
Cannabis Sativa logo
CBDS
Cannabis Sativa
0.5$0.72+1.4%$0.00N/A0.00
FRLF
Freedom Leaf
0.5$0.01+0.0%$0.00N/A0.00High Trading Volume
Gap Up
FUTL
FutureLand
0.4$0.00+0.0%$0.00N/A0.00
GB Sciences logo
GBLX
GB Sciences
0.5$0.05+7.7%$0.00N/A0.00Increase in Short Interest
Gap Down
GreenGro Technologies logo
GRNH
GreenGro Technologies
0.6$0.02+7.6%$0.00N/A0.00News Coverage
Gap Up
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$2.88+2.0%$0.00N/A0.00Gap Down
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01+0.0%$0.00N/A0.00Increase in Short Interest
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.04+8.5%$0.00N/A0.00News Coverage
Gap Up
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00+12.5%$0.00N/A0.00Gap Up
Northsight Capital logo
NCAP
Northsight Capital
0.5$0.00+60.0%$0.00N/A0.00Gap Down
OWC Pharmaceutical Research logo
OWCP
OWC Pharmaceutical Research
0.6$0.01+2.1%$0.00N/A0.00Gap Down
Surna logo
SRNA
Surna
0.6$0.06+3.1%$0.00N/A0.00Gap Up
Ultrack Systems logo
MJLB
Ultrack Systems
0.6$0.09+3.2%$0.00N/A0.00Gap Up
BUDZ
WEED
0.6$0.52+0.0%$0.00N/A0.00Gap Down
Zoned Properties logo
ZDPY
Zoned Properties
0.6$0.59+2.6%$0.00N/A0.00Gap Down
ZZLL
ZZLL Information Technology
0.4$0.32+0.0%$0.00N/A0.00
This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.